Ratings by TD Cowen (Matthew Blackman)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/12/2026 | SI-BONE Inc. | SIBN | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2026 | Alphatec Holdings | ATEC | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2026 | Stryker | SYK | Maintain | Hold (N/A) |
|
Details | ||
| 4/20/2026 | Tandem Diabetes Care | TNDM | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2026 | Globus Medical | GMED | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2026 | SI-BONE Inc. | SIBN | Maintain | Buy (N/A) |
|
Details | ||
| 1/27/2026 | Alphatec Holdings | ATEC | Maintain | Buy (N/A) |
|
Details | ||
| 1/27/2026 | SI-BONE Inc. | SIBN | New Coverage | Buy (N/A) |
16.80 (17.56) |
4.52% | Details | |
| 1/27/2026 | Alphatec Holdings | ATEC | New Coverage | Buy (N/A) |
15.62 (9.58) |
-38.67% | Details | |
| 1/27/2026 | Globus Medical | GMED | New Coverage | Buy (N/A) |
92.52 (78.11) |
-15.58% | Details | |
| 1/27/2026 | Tandem Diabetes Care | TNDM | New Coverage | Buy (N/A) |
19.90 (15.41) |
-22.56% | Details | |
| 1/27/2026 | Zimmer Biomet | ZBH | New Coverage | Buy (N/A) |
86.60 (91.34) |
5.47% | Details | |
| 1/27/2026 | Insulet Corporation | PODD | New Coverage | Hold (N/A) |
271.60 (161.28) |
-40.62% | Details | |
| 1/27/2026 | Intuitive Surgical | ISRG | New Coverage | Buy (N/A) |
523.99 (406.78) |
-22.37% | Details |
